Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
Active, not recruiting · NCT05451771 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, proteostasis deficiencies | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT05451771 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Columbia University | 375 |
| Genentech, Inc. | 221 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Medical Center | Boston | United States | 200 |
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | United States | 31 |
| Mayo Clinic Rochester | Rochester | United States | 133 |
| New York Presbyterian Hospital/Columbia University Irving Medical Center | New York | United States | 4 |